191 related articles for article (PubMed ID: 3707583)
1. Stereochemistry of estrogen biosynthesis by a reconstituted aromatase cytochrome P-450 preparation from human placenta.
Muto N; Tan L
Biochem Biophys Res Commun; 1986 Apr; 136(2):454-62. PubMed ID: 3707583
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of intermediates and isotopically sensitive enolization distinguish between aromatase (cytochrome P450 CYP19) from rat ovary and human placenta.
Swinney DC; Watson DM; So OY
Arch Biochem Biophys; 1993 Aug; 305(1):61-7. PubMed ID: 8342956
[TBL] [Abstract][Full Text] [Related]
3. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase.
Osawa Y; Higashiyama T; Shimizu Y; Yarborough C
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):469-80. PubMed ID: 8476762
[TBL] [Abstract][Full Text] [Related]
4. Human placental estrogen synthetase (aromatase). Effect of environment on the kinetics of protein-protein and substrate-protein interactions and the production of 19-oxygenated androgen intermediates in the purified reconstituted cytochrome P450 enzyme system.
Sethumadhavan K; Bellino FL
J Steroid Biochem Mol Biol; 1991 Sep; 39(3):381-94. PubMed ID: 1911429
[TBL] [Abstract][Full Text] [Related]
5. Aromatase and estrogen 2-hydroxylase activities of human placental microsomes in pregnancy-induced hypertension.
Okubo K; Jinbo M; Toma Y; Shimizu Y; Yanaihara T
Endocr J; 1996 Aug; 43(4):363-8. PubMed ID: 8930523
[TBL] [Abstract][Full Text] [Related]
6. Competitive product inhibition of aromatase by natural estrogens.
Shimizu Y; Yarborough C; Osawa Y
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):651-6. PubMed ID: 8476777
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of estrogen biosynthesis. Stereochemistry of C-1 hydrogen elimination in the aromatization of 2 beta-hydroxy-19-oxoandrostenedione.
Fishman J; Raju MS
J Biol Chem; 1981 May; 256(9):4472-7. PubMed ID: 7012154
[TBL] [Abstract][Full Text] [Related]
8. Purification and reconstitution properties of human placental aromatase. A cytochrome P-450-type monooxygenase.
Tan L; Muto N
Eur J Biochem; 1986 Apr; 156(2):243-50. PubMed ID: 3084250
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
[TBL] [Abstract][Full Text] [Related]
10. Tritium release from [19-3H]-19,19-difluoroandrost-4-ene-3,17-dione during inactivation of aromatase.
Furth PS; Robinson CH
Biochemistry; 1989 Feb; 28(3):1254-9. PubMed ID: 2653438
[TBL] [Abstract][Full Text] [Related]
11. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
Covey DF; Hood WF
Cancer Res; 1982 Aug; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
[TBL] [Abstract][Full Text] [Related]
12. Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro.
Almadhidi J; Moslemi S; Drosdowsky MA; Séralini GE
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):55-61. PubMed ID: 9009238
[TBL] [Abstract][Full Text] [Related]
13. Quantitative requirements for NADPH in the support of aromatization by human placental microsomes.
Sheean LA; Meigs RA
Steroids; 1981 Aug; 38(2):211-20. PubMed ID: 7303032
[TBL] [Abstract][Full Text] [Related]
14. Novel properties of human placental aromatase as cytochrome P-450: purification and characterization of a unique form of aromatase.
Harada N
J Biochem; 1988 Jan; 103(1):106-13. PubMed ID: 3129418
[TBL] [Abstract][Full Text] [Related]
15. Aromatase.
Osawa Y; Higashiyama T; Fronckowiak M; Yoshida N; Yarborough C
J Steroid Biochem; 1987; 27(4-6):781-9. PubMed ID: 3320558
[TBL] [Abstract][Full Text] [Related]
16. A comparison of methods measuring aromatase activity in human placenta and rat ovary.
Purba HS; Bhatnagar AS
J Enzyme Inhib; 1990; 4(2):169-78. PubMed ID: 2151521
[TBL] [Abstract][Full Text] [Related]
17. Stereochemistry of the functional group determines the mechanism of aromatase inhibition by 6-bromoandrostenedione.
Osawa Y; Osawa Y; Coon MJ
Endocrinology; 1987 Sep; 121(3):1010-6. PubMed ID: 3622372
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
Abul-Hajj YJ; Liu XP; Hedge M
Steroids; 1995 May; 60(5):423-7. PubMed ID: 7570717
[TBL] [Abstract][Full Text] [Related]
19. Steroidal inhibitors as chemical probes of the active site of aromatase.
Brueggemeir RW; Moh PP; Ebrahimian S; Darby MV
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):357-65. PubMed ID: 8476749
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human placental aromatase by 6 alpha- and 6 beta-hydroperoxyandrostenedione.
Tan L; Petit A
Biochem Biophys Res Commun; 1985 Apr; 128(2):613-20. PubMed ID: 3994715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
